Papers/PMID:28038881
Green tea (Camellia sinensis) for patients with knee osteoarthritis: A randomized open-label active-controlled clinical trial.
Clinical nutrition (Edinburgh, Scotland)2018The record
2 findings drawn from this paper, on 1 compound across 2 endpoints.
What it reported
How to read these marksWhat moved
2 findings
Camellia sinensis — decreases visual analogue scale pain intensity
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Finding“Mean differences of VAS pain, total WOMAC, and WOMAC physical function scores in green tea group showed a significant reduction, compared with the control group (P = 0.038, P = 0.006, and P = 0.004, respectively).”
Quoted verbatim from Green tea (Camellia sinensis) for patients with knee osteoarthritis: A randomized open-label active-controlled clinical trial.. - Study
- RCT
- Duration
- 4 weeks
- Population
- Adults with knee osteoarthritis; diclofenac tablet given as background in both arms
Green tea (Camellia sinensis) for patients with knee osteoarthritis: A randomized open-label active-controlled clinical trial.2018PMID:28038881
Camellia sinensis — decreases WOMAC physical function subscale
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Finding“Mean differences of VAS pain, total WOMAC, and WOMAC physical function scores in green tea group showed a significant reduction, compared with the control group (P = 0.038, P = 0.006, and P = 0.004, respectively).”
Quoted verbatim from Green tea (Camellia sinensis) for patients with knee osteoarthritis: A randomized open-label active-controlled clinical trial.. - Study
- RCT
- Duration
- 4 weeks
- Population
- Adults with knee osteoarthritis; diclofenac tablet given as background in both arms
Green tea (Camellia sinensis) for patients with knee osteoarthritis: A randomized open-label active-controlled clinical trial.2018PMID:28038881